Please enable Javascript
Matthew Deek, MD
Matthew Deek, MD, Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ
Articles by Matthew Deek, MD
Metastasis-Directed Therapy for Genitourinary Malignancies: Progress and Potential
Matthew Deek, MD
Prostate Cancer
|
October 31, 2023
Dr. Deek provides an overview of metastasis-directed therapy and the research in GU where such therapies have shown promise.
View More
Dr. Deek on the Prognostic Significance of Immune Cell Infiltration in MIBC
Matthew Deek, MD
ASCO 2023
|
June 4, 2023
Dr. Deek highlights his analysis of NRG RTOG 0524 and 0712 for prognostic significance of immune cell infiltration in MIBC.
View More
The Future of Personalized Care in Oligometastatic Prostate Cancer
Matthew Deek, MD
mCSPC
|
October 12, 2023
Dr. Deek shares what research should be done to better personalize care for patients with oligometastatic prostate cancer.
View More
High-Risk Mutations in Oligometastatic Prostate Cancer Patients
Matthew Deek, MD
mCSPC
|
October 12, 2023
Dr. Deek shares what “high-risk mutation” signified in his study and how patients with “high-risk mutation” should be ...
View More
PSMA Imaging in Oligometastatic Prostate Cancer
Matthew Deek, MD
Prostate Cancer Diagnostics
|
October 12, 2023
Dr. Deek shares how PSMA imaging used in both the STOMP and ORIOLE trials.
View More
MDT in omCSPC in the ORIOLE and STOMP Trials
Matthew Deek, MD
mCSPC
|
October 12, 2023
Dr. Deek shares how he evaluated long-term outcomes of MDT in om CSPC in both the ORIOLE and STOMP trials.
View More